Immediate Impact
1 by Nobel laureates 7 from Science/Nature 63 standout
Citing Papers
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
2015 Standout
Chemistry, Biology, and Medicine of Fluorescent Nanomaterials and Related Systems: New Insights into Biosensing, Bioimaging, Genomics, Diagnostics, and Therapy
2014 Standout
Works of S. Edgerton being referenced
Docetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-Institutional Phase II Trial
2004
Activation (Tyrosine Phosphorylation) of ErbB-2 (HER-2/neu): A Study of Incidence and Correlation With Outcome in Breast Cancer
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| S. Edgerton | 290 | 153 | 270 | 8 | 558 | |
| A. C. Diserens | 183 | 109 | 200 | 9 | 512 | |
| Rena D. Callahan | 384 | 123 | 330 | 10 | 618 | |
| Padma Sundareshan | 280 | 116 | 242 | 11 | 550 | |
| Cyrus Amir | 252 | 90 | 195 | 13 | 643 | |
| John Latigo | 138 | 173 | 256 | 9 | 539 | |
| M. Bennett | 293 | 108 | 214 | 5 | 581 | |
| Roza Zandi | 260 | 60 | 321 | 9 | 534 | |
| Neha Luthar | 292 | 76 | 235 | 6 | 522 | |
| Heather Kostner | 410 | 206 | 261 | 12 | 618 | |
| Hua-Zhong Zhang | 220 | 81 | 219 | 14 | 488 |
All Works
Loading papers...